SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/3DEF97E544B231AA8D4670425183B23064301BF647E41F92B23C3FB2D1EB65C0771EE1A2D31648DE248200D03E5E57BD>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/3DEF97E544B231AA8D4670425183B23064301BF647E41F92B23C3FB2D1EB65C0771EE1A2D31648DE248200D03E5E57BD
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/3DEF97E544B231AA8D4670425183B23064301BF647E41F92B23C3FB2D1EB65C0771EE1A2D31648DE248200D03E5E57BD
http://www.w3.org/2000/01/rdf-schema#comment
"Pharmacological inhibitors of SYK activity significantly reduced the engulfment of oxLDL microbeads in the presence of serum factors but had little effect on IgG phagocytosis."
xsd:string
http://purl.uniprot.org/uniprot/#_BB128959039CD04320727C8A81E380BD480D1977DE0899A27F68E7F2C20BF62DBAB3818CEDBCCED30790F0871162626A
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/3DEF97E544B231AA8D4670425183B23064301BF647E41F92B23C3FB2D1EB65C0771EE1A2D31648DE248200D03E5E57BD
http://purl.uniprot.org/uniprot/B3KQJ1
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/3DEF97E544B231AA8D4670425183B23064301BF647E41F92B23C3FB2D1EB65C0771EE1A2D31648DE248200D03E5E57BD
http://purl.uniprot.org/uniprot/#_B3KQJ1-mappedCitation-27510553
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/3DEF97E544B231AA8D4670425183B23064301BF647E41F92B23C3FB2D1EB65C0771EE1A2D31648DE248200D03E5E57BD